Alixir 20blue 20logo


Faster, cheaper, and more accurate ... Scalable AI for breast cancer screening.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location Sydney NSW, Australia
  • Currency AUD
  • Founded September 2017
  • Employees 2
  • Incorporation Type LLC
  • Website

Company Summary

Alixir is a healthtech company that applies deep learning to improve healthcare efficiency and outcomes. Our launch product AIMS provides a scalable mammogram analyser at significantly lower cost - yet higher accuracy - than what can currently be provided by radiologists. As a result we can make existing breast screen programs more cost-effective, save even more lives, and perhaps one day enable their introduction into developing countries too.


  • B14760a9 da7c 4d89 afd5 966a9f0a7f4f
    Co-founder, CTO

    A qualified medical doctor with over two decades’ experience in machine learning. Currently doing a PhD in applied deep learning in mammography.

  • Default avatar
    Jim Harding

    A market disrupter with roots going back to the original team that developed DOS and sold it to Microsoft, Jim was the VP of Technology at Amazon where he led the team that developed the technology platform for the Marketplace. He also founded ServerWare (which sold to Microsoft as part of SQL Server), as well as running Cartia, an award-winning pioneer in early big data machine learning techniques.

  • Default avatar
    Cliff Monlux
    Board Advisor

    Over 25 years experience starting, growing, investing, and selling market leading technology companies. As a founder of Paradigm Technology Partners he helped launch such companies as Docusign, and has been involved in launching and financing companies which have created more than US$12 Billion in market value. Currently a managing partner at Ramp Equity Partners.


  • Default avatar
    Sebastien Eckersley-Maslin

Previous Investors

  • Default avatar